AIMC Topic: Drug Development

Clear Filters Showing 291 to 300 of 333 articles

Effective drug-target interaction prediction with mutual interaction neural network.

Bioinformatics (Oxford, England)
MOTIVATION: Accurately predicting drug-target interaction (DTI) is a crucial step to drug discovery. Recently, deep learning techniques have been widely used for DTI prediction and achieved significant performance improvement. One challenge in buildi...

Integrating specific and common topologies of heterogeneous graphs and pairwise attributes for drug-related side effect prediction.

Briefings in bioinformatics
MOTIVATION: Computerized methods for drug-related side effect identification can help reduce costs and speed up drug development. Multisource data about drug and side effects are widely used to predict potential drug-related side effects. Heterogeneo...

Heterogeneous multi-scale neighbor topologies enhanced drug-disease association prediction.

Briefings in bioinformatics
MOTIVATION: Identifying new uses of approved drugs is an effective way to reduce the time and cost of drug development. Recent computational approaches for predicting drug-disease associations have integrated multi-sourced data on drugs and diseases....

DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph.

Briefings in bioinformatics
Drug-target interaction (DTI) prediction plays an important role in drug repositioning, drug discovery and drug design. However, due to the large size of the chemical and genomic spaces and the complex interactions between drugs and targets, experime...

An inductive graph neural network model for compound-protein interaction prediction based on a homogeneous graph.

Briefings in bioinformatics
Identifying the potential compound-protein interactions (CPIs) plays an essential role in drug development. The computational approaches for CPI prediction can reduce time and costs of experimental methods and have benefited from the continuously imp...

Pre-training graph neural networks for link prediction in biomedical networks.

Bioinformatics (Oxford, England)
MOTIVATION: Graphs or networks are widely utilized to model the interactions between different entities (e.g. proteins, drugs, etc.) for biomedical applications. Predicting potential interactions/links in biomedical networks is important for understa...

Learning multi-scale heterogenous network topologies and various pairwise attributes for drug-disease association prediction.

Briefings in bioinformatics
MOTIVATION: Identifying new therapeutic effects for the approved drugs is beneficial for effectively reducing the drug development cost and time. Most of the recent computational methods concentrate on exploiting multiple kinds of information about d...

ALDPI: adaptively learning importance of multi-scale topologies and multi-modality similarities for drug-protein interaction prediction.

Briefings in bioinformatics
MOTIVATION: Effective computational methods to predict drug-protein interactions (DPIs) are vital for drug discovery in reducing the time and cost of drug development. Recent DPI prediction methods mainly exploit graph data composed of multiple kinds...

Drug-target interaction predication via multi-channel graph neural networks.

Briefings in bioinformatics
Drug-target interaction (DTI) is an important step in drug discovery. Although there are many methods for predicting drug targets, these methods have limitations in using discrete or manual feature representations. In recent years, deep learning meth...

Artificial Intelligence in Drug Design: Are We Still There?

Current topics in medicinal chemistry
BACKGROUND: The artificial intelligence (AI)-assisted design of drug candidates with novel structures and desired properties has received significant attention in the recent past, so related areas of forward prediction that aim to discover chemical m...